Treatment of systemic sclerosis-associated digital ulcers: recommendations of the Turkish Society for Rheumatology

Basit Öğe Kaydı
dc.authorscopusid57207689067
dc.authorscopusid8535055500
dc.authorscopusid57826787200
dc.authorscopusid57211086192
dc.authorscopusid24536798400
dc.authorscopusid58126774600
dc.authorscopusid55904912300
dc.contributor.authorTemiz, Karadag, D.
dc.contributor.authorYalçınkaya, Y.
dc.contributor.authorAkdoğan, A.
dc.contributor.authorAvanoğlu, A.
dc.contributor.authorBeş, C.
dc.contributor.authorBirlik, A.M.
dc.contributor.authorErdoğan, M.
dc.date.accessioned2024-08-25T18:36:17Z
dc.date.available2024-08-25T18:36:17Z
dc.date.issued2023
dc.departmentEge Üniversitesien_US
dc.description.abstractOBJECTIVES: Digital ulcers (DUs) are associated with a significant burden in systemic sclerosis (SSc) by leading to severe pain, physical disability, and reduced quality of life. This effort aimed to develop recommendations of the Turkish Society for Rheumatology (TRD) on the management of DUs associated with SSc. METHODS: In the first meeting held in December 2020 with the participation of a task force consisting of 23 rheumatologists the scope of the recommendations and research questions were determined. A systematic literature review was conducted by 5 fellows and results were presented to the task force during the second meeting. The Oxford system was used to determine the level of evidence. The preliminary recommendations were discussed, modified, and voted by the task force and then by members of TRD via e-mail invitation allowing personalised access to a web-based questionnaire [SurveyMonkey®]. RESULTS: A total of 23 recommendations under 7 main headings were formulated covering non-pharmacological measures for the prevention of DUs and pharmacological treatments including vasodilators, anti-aggregants, antibiotics, wound care, pain control, and interventions including sympathectomy, botulinum toxin, and surgery. Risk factors, poor prognostic factors, prevention of DU and adverse effects of medical treatments were reported as 4 overarching principles. CONCLUSIONS: These evidence-based recommendations for the management of SSc-associated DUs were developed to provide a useful guide to all physicians who are involved in the care of patients with SSc, as well as to point out unmet needs in this field.en_US
dc.identifier.doi10.55563/clinexprheumatol/ce13vk
dc.identifier.endpage1687en_US
dc.identifier.issn0392-856X
dc.identifier.issue8en_US
dc.identifier.pmid37470234en_US
dc.identifier.scopus2-s2.0-85166442153en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage1679en_US
dc.identifier.urihttps://doi.org/10.55563/clinexprheumatol/ce13vk
dc.identifier.urihttps://hdl.handle.net/11454/100588
dc.identifier.volume41en_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherNLM (Medline)en_US
dc.relation.ispartofClinical and experimental rheumatologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.snmz20240825_Gen_US
dc.subjectcomplicationen_US
dc.subjectfingeren_US
dc.subjectfinger ulceren_US
dc.subjecthumanen_US
dc.subjectpainen_US
dc.subjectquality of lifeen_US
dc.subjectrheumatologyen_US
dc.subjectskin ulceren_US
dc.subjectsystemic sclerosisen_US
dc.subjectdigital ulcersen_US
dc.subjectFingersen_US
dc.subjectHumansen_US
dc.subjectPainen_US
dc.subjectQuality of Lifeen_US
dc.subjectRheumatologyen_US
dc.subjectScleroderma, Systemicen_US
dc.subjectSkin Ulceren_US
dc.titleTreatment of systemic sclerosis-associated digital ulcers: recommendations of the Turkish Society for Rheumatologyen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu